another example is ELN they never got back to there ultimate high of $61, but did recover some.
Possible buyout and they can advance on technology, given small MC, but for what price?
Sentiment: Strong Buy
DNDN was $58 and has been stuck under $10 and at one time $3.69?
doesn't mean anything in the world of biotechs. This could stay at $3-3.50 range for quite some time. Don't think it'll spring back to $25 soon.
CLSN dropped from $9 to $1, might get a small pop soon but unless news comes out it'll stay under $2 and that goes for many bio-tech stocks out there.
I am but would like Longs input, always helps. Too much trash out there if you know what I mean ;)
get lost punk!
this part is important:
Subset data analysis could come at any time, and this will likely be the catalyst for a bounceback.
This was a stock we profiled last month in our article, "Speculative Boiptech Stocks That Could Bounce", and in that article, we noted the oversold chart and the expected move back to $1.60. A week later, the stock popped to an intra-day high of $1.54 for a 30% gain. Since then, there has been a slow bleed, thanks to news of financing competed at $1.24 per share. Now that financing has been completed, the company has approximately $35m in cash. Celsion has been consolidating over the last two weeks since that news at the $1 level, and could be setting up for another bounceback. Subset data analysis could come at any time, and this will likely be the catalyst for a bounceback. Also, with the financing completed at $1.24 and the stock hovering at $1, there is good reason to expect a bounce back to that price level near term. With a market cap of $50m and some small hope for positive news in their other trials there is reason to put some speculative money in this play. A bounce back to the February $1.54 highs would mark a 50% return from here.
You are a smart investor, buyout not happening with what is going on. This will drift sideways for some time and possibly have some pops here and there. Who ever bought/shorted/covered did there thing for what ever reasons. Retailers are always the last to know.
Anything can happen but looking at it realistically I would be cautious.
Earnings Call should give some clarity to future of CLSN, expect a small pop going into earnings.
You are stating that AFFY met with Pfizer? Can you support this claim?